Price
Target price
€48.70
€48.70
-0.630%
-0.31
-0.630%
€93.59
12.08.25 / Tradegate
WKN: 924801 / Symbol: BMRN / Name: BioMarin Pharmaceutical / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock BioMarin Pharmaceutical Inc. is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for BioMarin Pharmaceutical
sharewise wants to provide you with the best news and tools for BioMarin Pharmaceutical, so we directly link to the best financial data sources.
Financials
News
Biomarin Pharmaceutical Stock: Strong Data Boosts Outlook
Biomarin Pharmaceutical recently presented compelling new data for its key medications VOXZOGO and PALYNZIQ at the American College of Medical Genetics and Genomics annual meeting, sparking investor
Biomarin Pharmaceutical Stock: Q4 Profits Soar, 2025 Outlook Strong
Biomarin Pharmaceutical has demonstrated remarkable financial performance in the fourth quarter, with net profits reaching $125 million, translating to earnings per share of $0.64—a substantial